NeuroBo Pharmaceuticals Inc (NRBO)
2.335
-0.06
(-2.30%)
USD |
NASDAQ |
Nov 15, 12:17
NeuroBo Pharmaceuticals Cash from Financing (Quarterly): -0.676M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.676M |
| June 30, 2024 | 19.20M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.08M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 28.82M |
| September 30, 2022 | -0.134M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 12.89M |
| September 30, 2021 | -0.024M |
| June 30, 2021 | 0.072M |
| March 31, 2021 | 9.092M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 6.805M |
| March 31, 2020 | 0.053M |
| December 31, 2019 | 0.001M |
| Date | Value |
|---|---|
| September 30, 2019 | -0.009M |
| June 30, 2019 | 24.18M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -5.885M |
| September 30, 2018 | 0.051M |
| June 30, 2018 | -0.144M |
| March 31, 2018 | 23.22M |
| December 31, 2017 | -0.107M |
| September 30, 2017 | 10.15M |
| June 30, 2017 | -0.172M |
| March 31, 2017 | 11.47M |
| December 31, 2016 | -0.713M |
| September 30, 2016 | 27.18M |
| June 30, 2016 | 4.927M |
| March 31, 2016 | 0.065M |
| December 31, 2015 | 2.525M |
| September 30, 2015 | 2.724M |
| June 30, 2015 | 1.18M |
| March 31, 2015 | 2.307M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.676M
Minimum
Sep 2024
28.82M
Maximum
Dec 2022
3.800M
Average
--
Median
Sep 2020
Cash from Financing (Quarterly) Benchmarks
| Cytokinetics Inc | 3.425M |
| Ocugen Inc | 0.045M |
| enVVeno Medical Corp | 13.59M |
| Scholar Rock Holding Corp | -0.033M |
| Mirum Pharmaceuticals Inc | 7.291M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.589M |
| Free Cash Flow | -22.69M |
| Free Cash Flow Per Share (Quarterly) | -0.5472 |
| Free Cash Flow Yield | -150.5% |